Financial risks posed by unproven stem cell interventions in Japan
The research group led by Professor Misao Fujita conducted a study to estimate the total amount the Japanese government would refund if a patient received unproven cell interventions and applied for a medical expense deduction.
Apr 27, 2022
0
2